Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex by Elena Gangitano, Francesca Scannapieco, Carla Lubrano, Lucio Gnessi

Subjects: Get full text

Lipid Hormones at the Intersection of Metabolic Imbalances and Endocrine Disorders by Maria-Zinaida Dobre, Bogdana Virgolici, Ruxandra Cioarcă-Nedelcu

Subjects: Get full text

Clinical Outcomes Following a Patient-Centered Educational Intervention on Steatotic Liver Disease: A Comparison of Patients With and Without Diabetes by Rebecca G. Kim, Shyam Patel, Amy M. Shui, Catherine Magee, Jennifer Y. Chen, Michele Tana, Mandana Khalili

Subjects: “…MASLD…”
Get full text

The emerging role of E3 ubiquitin ligases and deubiquitinases in metabolic dysfunction-associated steatotic liver disease by Yu Zhang, Jiahui Yang, Jiali Min, Shan Huang, Yuchen Li, Shanshan Liu

Subjects: Get full text

Inflammatory and metabolic markers mediate the association of hepatic steatosis and fibrosis with 10-year ASCVD risk by Zihao Gui, Xingying Chen, Dongmei Wang, Zhi Chen, Siyang Liu, Genfeng Yu, Yuqi Jiang, Hualin Duan, Daoyan Pan, Xu Lin, Lan Liu, Heng Wan, Jie Shen

Subjects: Get full text

Allantoin Serves as a Novel Risk Factor for the Progression of MASLD by Weiqiang Lv, Xueqiang Wang, Zhaode Feng, Cunxiao Sun, Hansen Wu, Mengqi Zeng, Tianlin Gao, Ke Cao, Jie Xu, Xuan Zou, Tielin Yang, Hao Li, Lei Chen, Jiankang Liu, Shanshan Dong, Zhihui Feng

Subjects: “…MASLD…”
Get full text

Clopidogrel ameliorates high-fat diet-induced hepatic steatosis in mice through activation of the AMPK signaling pathway and beyond by Ting Tai, Ting Tai, Ting Tai, Yuan-Yuan Shao, Yuan-Yuan Shao, Yu-Qi Zheng, Yu-Qi Zheng, Li-Ping Jiang, Li-Ping Jiang, Hao-Ru Han, Hao-Ru Han, Na Yin, Na Yin, Hao-Dong Li, Hao-Dong Li, Jin-Zi Ji, Jin-Zi Ji, Qiong-Yu Mi, Qiong-Yu Mi, Li Yang, Li Yang, Lei Feng, Lei Feng, Fu-Yang Duan, Fu-Yang Duan, Hong-Guang Xie, Hong-Guang Xie, Hong-Guang Xie, Hong-Guang Xie

Subjects: Get full text

Development of SOCS1 mimetics as novel approach to harmonize inflammation, oxidative stress, and fibrogenesis in metabolic dysfunction-associated steatotic liver disease by Susana Bernal, Ignacio Prieto, María Kavanagh, Isabel Herrero del Real, Sara La Manna, Iolanda Lázaro, Hernán Quiceno, Laura López-Sanz, Belén Picatoste, M. Pilar Valdecantos, Sebastián Mas-Fontao, Aleix Sala-Vila, Ángela M. Valverde, Daniela Marasco, Jesús Egido, Carmen Gómez-Guerrero

Subjects: “…MASLD…”
Get full text

Comparison of sarcopenia screening indices using serum creatinine and cystatin C in metabolic dysfunction-associated steatotic liver disease by Inyoung Hwang, Shi-Ra Lee, Shi-Ra Lee, Yun Kim, Sang Won Lee, Sang Won Lee

Subjects: “…MASLD…”
Get full text

Enterotype-stratified gut microbial signatures in MASLD and cirrhosis based on integrated microbiome data by Heng Yuan, Heng Yuan, Junyu Zhou, Junyu Zhou, Xuangao Wu, Shiwei Wang, Sunmin Park, Sunmin Park

Subjects: “…MASLD…”
Get full text

Characterization of gut dysbiosis and intestinal barrier dysfunction in patients with metabolic dysfunction-associated steatotic liver disease and chronic kidney disease: a compara... by Thasinas Dissayabutra, Natthaya Chuaypen, Pornjira Somnark, Bootsakorn Boonkaew, Suwasin Udomkarnjananun, Piyawan Kittiskulnam, Pimpisa Charoenchittang, Pinidphon Prombutara, Pisit Tangkijvanich

Subjects: Get full text

BMI gain and dietary characteristics are risk factors of MASLD in non-obese individuals by Hirokazu Taniguchi, Miho Ueda, Yukiko Kobayashi, Takatomo Shima

Subjects: “…MASLD…”
Get full text

Golgi protein 73: charting new territories in diagnosing significant fibrosis in MASLD: a prospective cross-sectional study by Shan Hong, Ziyu Liu, Ping Li, Jing Zhang, Hongshan Wei

Subjects: “…MASLD…”
Get full text

Atherogenic index of plasma identifies subjects with severe liver steatosis by Carlo De Matteis, Fabio Novielli, Ersilia Di Buduo, Maria Arconzo, Raffaella Maria Gadaleta, Marica Cariello, Antonio Moschetta, Lucilla Crudele

Subjects: Get full text

Cardiometabolic Index as a predictor of mortality in metabolic Dysfunction-Associated Steatotic Liver Disease by Yang Yang, Cheng Zeng, Zhiqiang Jin, Yi Huang, Huabao Liu

Subjects: Get full text

Analyzing MASLD interventional clinical trial registration based on the ClinicalTrials.gov database by Hui Du, Jihan Huang, Youhua Wang, Chunyan Wang, Yiqun Wang, Luming Hou, Yali Li, Ying Li, Qianmin Su

Subjects: “…MASLD…”
Get full text

Mitochondrial ROS, a trigger for mitochondrial dysfunction and inflammasome activation and a therapeutic target in liver diseases by Hala Saeed Jaara, Sandra Torres

Subjects: Get full text

Fibrosis status, extrahepatic multimorbidity and all-cause mortality in 53,093 women and 74,377 men with metabolic dysfunction associated steatotic liver disease (MASLD) in UK biob... by Qi Feng, Chioma N. Izzi-Engbeaya, Pinelopi Manousou, Mark Woodward

Subjects: “…MASLD…”
Get full text

Humanized monoacylglycerol acyltransferase 2 mice develop metabolic dysfunction-associated steatohepatitis by J. Jose Corbalan, Pranavi Jagadeesan, Karla K. Frietze, Rulaiha Taylor, Grace L. Gao, Grant Gallagher, Joseph T. Nickels, Jr.

Subjects: Get full text

A cross-sectional study of risk factors associated with sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease by Johnny Amer, Qusay Abdoh, Zaina Salous, Eithar Abu Alsoud, Sama AbuBaker, Ahmad Salhab, Manal Badrasawi

Subjects: “…MASLD…”
Get full text